Digestive Disorders in Dogs and Cats: Stabilisation and Supporting Gut Health

Gastrointestinal disturbances remain one of the most frequent presentations in small animal practice. Both acute and chronic cases commonly involve disruption to intestinal barrier function, fluid and electrolyte homeostasis, and the luminal microbial ecosystem.

A pragmatic clinical approach can be considered in two phases: early stabilisation, followed by targeted nutritional support of gastrointestinal recovery and microbial re-equilibration.

Acute Phase: Stabilisation and Symptom Management

In acute diarrhoeic presentations, initial priorities typically centre on correction of hydration status, maintenance of electrolyte balance, and mitigation of further disruption to the intestinal environment.

Role of Electrolytes

Acute enteropathies are frequently associated with significant fluid and electrolyte loss, including sodium, potassium, and chloride, with potential downstream effects on cellular function and acid–base balance.

Oral electrolyte supplementation may be used to:

• Support maintenance of extracellular fluid volume

• Contribute to physiological electrolyte balance

• Provide readily absorbable substrates during periods of reduced voluntary intake

These products are used as adjuncts to clinical assessment and, where indicated, parenteral fluid therapy.

Role of Bentonite

Bentonite is a hydrated aluminium silicate with a high surface area and adsorptive capacity.

Within the gastrointestinal tract, it is used with the aim of:

• Increasing luminal water binding, thereby supporting stool consistency

• Adsorbing a range of luminal compounds, including bacterial metabolites and toxins

• Contributing to a more stable intestinal environment during acute disruption

Its use may be beneficial in improving faecal consistency in acute diarrhoeic states, supporting overall case management alongside appropriate diagnostics and therapy.

Practical Application

Products such as EasyPill Digest Comfort combine palatability with functional ingredients including high levels of bentonite and are used in practice:

• To support digestive comfort during acute gastrointestinal upset

• To facilitate voluntary intake in patients with hyporexia

• To improve compliance when co-administering prescribed treatments

They should be positioned as supportive nutritional adjuncts rather than interventions targeting underlying pathology.

Recovery Phase: Supporting Gut Function and Microbial Balance

Following initial stabilisation, clinical focus often shifts towards restoration of intestinal function, including epithelial integrity, digestive capacity, and microbial homeostasis.

The Microbiome and Gut Recovery

Dysbiosis—characterised by alterations in microbial diversity, composition, and metabolic activity—is well documented following acute gastrointestinal disease, dietary perturbation, and antimicrobial administration.

This disruption may be associated with:

• Reduced production of short-chain fatty acids (SCFAs), particularly butyrate

• Altered bile acid metabolism

• Impaired mucosal barrier function and immune signalling

Nutritional strategies aimed at supporting microbial balance are increasingly incorporated into recovery protocols.

Role of Probiotics and Postbiotics

Products containing probiotics and postbiotics, such as Precision Microbes, are used with the aim of supporting gastrointestinal homeostasis during recovery.

Probiotics

Probiotics are defined as live microorganisms which, when administered in adequate amounts, are intended to support the host’s intestinal microbial balance.

In the context of gastrointestinal support, they are used with the aim of:

• Contributing to competitive exclusion of pathogenic microorganisms

• Supporting epithelial barrier function through interactions with tight junction proteins

• Modulating local immune responses, including effects on mucosal immunoglobulin production and cytokine signalling

• Contributing to metabolic activity within the gut, including SCFA production

  
  

However, their effects are strain-specific and influenced by factors such as dose, viability, and gastrointestinal transit time. In practical terms, the freeze-dried composition of many probiotic products means they must pass through activation phases before becoming metabolically active. In acute gastrointestinal conditions, this delay can be clinically relevant, as many cases begin to resolve before the probiotic has had sufficient time to exert its full effect.

This highlights an important distinction between traditional freeze-dried probiotics and newer approaches involving live liquid postbiotic formulations, where active metabolites are immediately available.

Postbiotics

Postbiotics comprise non-viable microbial cells, cell components (e.g. peptidoglycans, lipoteichoic acids), and microbial metabolites.

They are of increasing interest in veterinary nutrition due to:

• Enhanced stability compared to live organisms (resistance to storage and environmental conditions)

• Consistent composition and activity profiles

• Ability to interact with host epithelial and immune pathways independent of microbial viability

  
  

Postbiotics are used with the aim of:

• Supporting epithelial barrier integrity via modulation of tight junctions

• Contributing to anti-inflammatory signalling pathways within the gut mucosa

• Providing metabolites such as SCFAs that serve as energy substrates for colonocytes

• Interacting with pattern recognition receptors (e.g. Toll-like receptors), influencing mucosal immune responses

  
  

Importantly, their role is supportive of normal physiological processes rather than corrective of disease states.

Integration in Clinical Practice

A phased nutritional approach may be considered:

• Short term: Electrolytes and adsorbent agents (e.g. bentonite) to support hydration and luminal stability

• Longer term: Microbiome-oriented support incorporating pro- and postbiotics to assist re-establishment of gastrointestinal equilibrium

  
  

Key considerations:

• Appropriate case selection and diagnostic work-up

• Use as adjuncts alongside standard-of-care treatments

• Clear communication with clients regarding expected role and limitations

  
  

Summary

Management of gastrointestinal disorders in dogs and cats may benefit from a structured, phased approach:

• Initial stabilisation: Supporting hydration, electrolyte balance, and luminal environment

• Recovery phase: Supporting restoration of intestinal function and microbial balance

Nutritional strategies incorporating electrolytes, adsorbent agents, and pro-/postbiotic formulations can be integrated as adjunctive measures within this framework.